chr8-133280273-A-G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_006096.4(NDRG1):​c.64-6T>C variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.567 in 1,612,932 control chromosomes in the GnomAD database, including 265,351 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.64 ( 32790 hom., cov: 32)
Exomes 𝑓: 0.56 ( 232561 hom. )

Consequence

NDRG1
NM_006096.4 splice_region, intron

Scores

3
Splicing: ADA: 0.000008000
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:13

Conservation

PhyloP100: 0.573

Publications

16 publications found
Variant links:
Genes affected
NDRG1 (HGNC:7679): (N-myc downstream regulated 1) This gene is a member of the N-myc downregulated gene family which belongs to the alpha/beta hydrolase superfamily. The protein encoded by this gene is a cytoplasmic protein involved in stress responses, hormone responses, cell growth, and differentiation. The encoded protein is necessary for p53-mediated caspase activation and apoptosis. Mutations in this gene are a cause of Charcot-Marie-Tooth disease type 4D, and expression of this gene may be a prognostic indicator for several types of cancer. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, May 2012]
NDRG1 Gene-Disease associations (from GenCC):
  • Charcot-Marie-Tooth disease type 4D
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Illumina, Labcorp Genetics (formerly Invitae), Orphanet

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_006096.4, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.73).
BP6
Variant 8-133280273-A-G is Benign according to our data. Variant chr8-133280273-A-G is described in ClinVar as Benign. ClinVar VariationId is 259916.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.855 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_006096.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
NDRG1
NM_006096.4
MANE Select
c.64-6T>C
splice_region intron
N/ANP_006087.2
NDRG1
NM_001374844.1
c.64-6T>C
splice_region intron
N/ANP_001361773.1
NDRG1
NM_001135242.2
c.64-6T>C
splice_region intron
N/ANP_001128714.1Q92597-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
NDRG1
ENST00000323851.13
TSL:1 MANE Select
c.64-6T>C
splice_region intron
N/AENSP00000319977.8Q92597-1
NDRG1
ENST00000522476.5
TSL:1
c.-99-15621T>C
intron
N/AENSP00000427894.1Q92597-2
NDRG1
ENST00000414097.6
TSL:2
c.64-6T>C
splice_region intron
N/AENSP00000404854.2Q92597-1

Frequencies

GnomAD3 genomes
AF:
0.640
AC:
97248
AN:
151950
Hom.:
32741
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.862
Gnomad AMI
AF:
0.499
Gnomad AMR
AF:
0.534
Gnomad ASJ
AF:
0.641
Gnomad EAS
AF:
0.463
Gnomad SAS
AF:
0.410
Gnomad FIN
AF:
0.579
Gnomad MID
AF:
0.649
Gnomad NFE
AF:
0.570
Gnomad OTH
AF:
0.648
GnomAD2 exomes
AF:
0.556
AC:
139553
AN:
251082
AF XY:
0.549
show subpopulations
Gnomad AFR exome
AF:
0.870
Gnomad AMR exome
AF:
0.469
Gnomad ASJ exome
AF:
0.635
Gnomad EAS exome
AF:
0.465
Gnomad FIN exome
AF:
0.577
Gnomad NFE exome
AF:
0.572
Gnomad OTH exome
AF:
0.577
GnomAD4 exome
AF:
0.560
AC:
817722
AN:
1460864
Hom.:
232561
Cov.:
43
AF XY:
0.555
AC XY:
403631
AN XY:
726762
show subpopulations
African (AFR)
AF:
0.879
AC:
29434
AN:
33468
American (AMR)
AF:
0.478
AC:
21357
AN:
44700
Ashkenazi Jewish (ASJ)
AF:
0.643
AC:
16794
AN:
26128
East Asian (EAS)
AF:
0.468
AC:
18580
AN:
39686
South Asian (SAS)
AF:
0.438
AC:
37811
AN:
86238
European-Finnish (FIN)
AF:
0.580
AC:
30942
AN:
53386
Middle Eastern (MID)
AF:
0.641
AC:
3696
AN:
5766
European-Non Finnish (NFE)
AF:
0.562
AC:
623959
AN:
1111140
Other (OTH)
AF:
0.582
AC:
35149
AN:
60352
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.470
Heterozygous variant carriers
0
17376
34752
52129
69505
86881
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
17414
34828
52242
69656
87070
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.640
AC:
97347
AN:
152068
Hom.:
32790
Cov.:
32
AF XY:
0.632
AC XY:
46944
AN XY:
74330
show subpopulations
African (AFR)
AF:
0.862
AC:
35777
AN:
41500
American (AMR)
AF:
0.534
AC:
8162
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.641
AC:
2222
AN:
3468
East Asian (EAS)
AF:
0.463
AC:
2391
AN:
5164
South Asian (SAS)
AF:
0.409
AC:
1974
AN:
4822
European-Finnish (FIN)
AF:
0.579
AC:
6107
AN:
10556
Middle Eastern (MID)
AF:
0.646
AC:
190
AN:
294
European-Non Finnish (NFE)
AF:
0.570
AC:
38708
AN:
67956
Other (OTH)
AF:
0.645
AC:
1361
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1645
3290
4935
6580
8225
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
754
1508
2262
3016
3770
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.599
Hom.:
29466
Bravo
AF:
0.653
Asia WGS
AF:
0.507
AC:
1765
AN:
3478
EpiCase
AF:
0.575
EpiControl
AF:
0.575

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
5
not specified (5)
-
-
3
Charcot-Marie-Tooth disease type 4D (3)
-
-
2
Charcot-Marie-Tooth disease type 4 (2)
-
-
2
not provided (2)
-
-
1
Charcot-Marie-Tooth disease (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.73
CADD
Benign
12
DANN
Benign
0.49
PhyloP100
0.57
PromoterAI
-0.0047
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.0000080
dbscSNV1_RF
Benign
0.0
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs2272653;
hg19: chr8-134292516;
COSMIC: COSV60484172;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.